Advisor Group Holdings »

Aligos Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Aligos Therapeutics shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9k 220 8.66

More positions owned by Advisor Group Holdings

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Aligos Therapeutics

Woodline Partners
Baker Bros. Advisors
Hillhouse Capital Advisors
Acadian Asset Management
Geode Capital Management
Renaissance Technologies
Charles Schwab Investment Management
BlackRock
Bank of America Corporation
CWM
Advisor Group Holdings
AlphaMark Advisors
Jpmorgan Chase & Co
Zrc Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding Aligos Therapeutics